Clinical Trials Logo
  1. Home
  2. HIV
  3. NCT00801515
  4. Details
NCT00801515 Clinical Trial

A Compassionate Access Protocol For Those Patients Who Have Completed A4001029

HIV Clinical Trial

Official title:
A Compassionate Access Protocol For Those Patients Who Have Completed A4001029

Clinical Trial Details — Status: No longer available

Administrative data
NCT number NCT00801515
Other study ID # A4001090
Secondary ID
Status No longer available
Phase Phase 3
First received December 2, 2008
Last updated July 21, 2011
Start date August 2009
Est. completion date July 2011

Study information
Verified date July 2011
Source ViiV Healthcare
Contact n/a
Is FDA regulated No
Health authority Canada: Therapeutic Products Directorate (TPD)
Study type Expanded Access

Clinical Trial Summary

This is a compassionate study to provide continued access to maraviroc for only those subjects completing study A4001029 who are showing clinical benefit. Assessments of safety and tolerability of maraviroc when added to OBT will be continued.

Recruitment information / eligibility
Status No longer available
Enrollment 0
Est. completion date July 2011
Est. primary completion date July 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients having completed study A4001029 in Canada and still deriving clinical benefit.

Exclusion Criteria:

Study Design

N/A

Related Conditions & MeSH terms

Intervention

Drug:
• Maraviroc
150 mg twice per day

Locations
Country Name City State
Canada Pfizer Investigational Site Montreal Quebec

Sponsors (2)
Lead Sponsor Collaborator
ViiV Healthcare Pfizer

Country where clinical trial is conducted

Canada, 

See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2

External Links